Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/TANGO-THERAPEUTICS-INC-111641934/news/Medivir-s-licensee-Tango-Therapeutics-has-dosed-the-first-patient-with-TNG348-a-novel-USP1-inhib-45671373/?utm_source=whatsapp&utm_medium=social&utm_campaign=share